Jennifer Letourneau, D.O., M.C.R., FACP, FCSM

  • Clinical Associate Professor of Medicine, Division of Pulmonary and Critical Care Medicine, School of Medicine
  • Section Chief, Pulmonary, Critical Care, Sleep, and Allergy Medicine at VA Portland

Biography

Dr. Jennifer LeTourneau is the section chief for Pulmonary, Critical Care, Sleep, and Allergy Medicine at the VA Portland Healthcare System in Portland, OR.  She has previously served in leadership roles in graduate medical education (GME) as clinical vice president, medical education and designated institutional official (DIO) at Legacy Health, Portland, OR.   She served a six-year term as a member of the Accreditation Council for Graduate Medical Education (ACGME) Institutional Review Committee, works as a coach in the University of Pennsylvania masters in medical education program, and has received local and national awards for mentoring women in medicine.  She has presented nationally on physician leadership, workforce development through graduate medical education initiatives, and organizational dynamics.  She enjoys teaching her children self-sufficiency via microwaving ramen, patience via trout fishing, and satire via Cunk on Earth.

Education and training

  • Degrees

    • B.A., 1993, University of Puget Sound
    • D.O., 2000, Western University of Health Sciences
    • M.C.R., 2009, Oregon Health and Science University

  • Residency

    • Internal Medicine, Oregon Health and Science University, 2000-2003

  • Fellowship

    • Critical Care Medicine, Oregon Health and Science University, 2006-2008

  • Certifications

    • American Board of Internal Medicine, Internal Medicine 2003
    • American Board of Internal Medicine, Critical Care Medicine 2008
    • National Board of Physicians and Surgeons, Internal Medicine 2015
    • National Board of Physicians and Surgeons, Critical Care Medicine 2015

Publications

Selected publications

  • Chan DK, Alegria BD, Chadaga SR, Goren LJ, Mikasa TJ, Pearson AM, Podolsky SR, Won RS, LeTourneau JL. Rapid Deployment of Multiple-Tactics to Address SARS-CoV-2 Vaccine Uptake in Healthcare Employees with a focus on Those Who Identify as Black, Indigenous, and People of Color (BIPOC). Open Forum Infectious Disease 2022 Mar;9(3):ofac012. https://doi.org/10.1093/ofid/ofac012
  • Bihorac A, Chawla L, Shaw A, Al-Khafaji A, Davison D, DeMuth G, Fitzgerald R, Gong M, Graham D, Gunnerson K, Heung M, Jortani S, Kleerup E, Koyner J, Krell K, LeTourneau J, Lissauer M, Miner J, Nguyen HB, Ortega L, Self W, Sellman R, Shi J, Kellum J, Straseski J, Szalados J, Wilber S, Walker M, Wilson J, Wunderink R, Zimmerman J. Validation of Cell-Cycle Arrest Biomarkers for Acute Kidney Injury Using Clinical Adjudication. AJRCCM 2014;189(8):932-9
  • Slatore CG, Cecere LM, LeTourneau JL, O'Neil ME, Duckart JP, Wiener RS, Cooke CR. Intensive Care Unit Outcomes among Patients with Lung Cancer in the SEER-Medicare Registry. Journal of Clinical Oncology 2012; 30 (14):1686-1691
  • LeTourneau JL, Pinney J, Phillips CR. Extravascular lung water predicts progression to acute lung injury in patients with increased risk. Crit Care Med 2012;40(3):847-854
  • Vernon C & LeTourneau JL. Lactic Acidosis: Recognition, Kinetics, and Associated Prognosis. Critical Care Clinics 2010;26:255-283
  • LeTourneau JL, Hagg DS, Smith, SM: Baclofen and gamma-hydroxybutyrate withdrawal. Neurocritical Care 2008; 8 (3): 430-433

Publications